As previously mentioned, in ccRCC cells, SETD2 deficiency is associated with the appearance of free ATG12, as well as the expression of additional ATG12-containing complexes, along with the recognized ATG12–ATG5 conjugate, and an overall increase in total ATG12 protein expression levels. The gene discussed is ATG12; the disease is nonpapillary renal cell carcinoma.